U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07234045) titled 'A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms' on Nov. 14.
Brief Summary: A Clinical Study to Explore the Safety, Efficacy and Cellular Metabolic Kinetics of CT1195E CAR-T Cells Injection in Patients with Relapsed/Refractory B-Cell Neoplasms
Study Start Date: Nov. 30
Study Type: INTERVENTIONAL
Condition:
Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Relapsed/Refractory B-cell ALL
Intervention:
DRUG: CAR T cells chimeric antigenreceptor cells
CT1195E cells infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Published ...